Dr. Aliprantis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
850 Boylston St
Ste 130
Chestnut Hill, MA 02467Phone+1 617-732-9519Fax+1 617-732-9577
Education & Training
- Brigham and Women's HospitalFellowship, Rheumatology, 2003 - 2007
- NYU Grossman School of MedicineResidency, Internal Medicine, 2001 - 2003
- New York University School of MedicineClass of 2001
Certifications & Licensure
- MA State Medical License 2003 - 2026
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 1212 citationsCell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2Antonios O. Aliprantis, Ruey-Bing Yang, Melanie R. Mark, Shelly Suggett, Brigitte Devaux
Science. 1999-07-30 - 261 citationsOsteoclasts: more than ‘bone eaters’Julia F. Charles, Antonios O. Aliprantis
Trends in Molecular Medicine. 2014-08-01 - 410 citationsThe apoptotic signaling pathway activated by Toll-like receptor-2.Antonios O. Aliprantis, Ruey-Bing Yang, David S. Weiss, Paul J. Godowski, Arturo Zychlinsky
The EMBO Journal. 2000-07-03
Press Mentions
- A Potent Broadly Neutralizing Human RSV Antibody Targets Conserved Site IV of the Fusion GlycoproteinSeptember 12th, 2020
Grant Support
- Regulation Of Osteoclast Biology By Anion Exchanger SLC4A2 In Mouse And Human SysNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Novel Regulatory Mechanisms Of The Osteoclast Transcriptional ProgramNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2011
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: